Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
about
State of the art management of metastatic gastroesophageal cancerA phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinomaCase of childhood laryngeal papillomatosis with metastatic carcinoma esophagus in adulthoodPhase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancerClinical Significance of Preoperative Thrombin Time in Patients with Esophageal Squamous Cell Carcinoma following Surgical Resection.Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer.Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer.A comparative study of cisplatin-based definitive chemo-radiation in non-metastatic squamous cell carcinoma of the esophagusNimotuzumab Combined with Chemotherapy is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer.A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinomaA retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma.Emerging tyrosine kinase inhibitors for esophageal cancer.Neoadjuvant chemoradiotherapy for resectable esophageal cancer: an in-depth study of randomized controlled trials and literature review.Emerging mAbs for the treatment of esophagogastric cancer.Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.Role of tumor necrosis factor alpha-induced protein 1 in paclitaxel resistance.Esophageal cancer chemotherapy: recent advances.A clinical trial protocol paper discussing the BRIGHTER study.A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol.
P2860
Q26779217-8484642A-4D27-4E27-8C0F-D4642B336065Q33410922-426C5B24-D1CA-4E33-BCBB-77BD8144BF88Q34859174-6D9B206D-96CA-4AA9-B0D5-C5BD8643762FQ35559881-497A16BF-23A1-4A96-A1CD-596FD5D27172Q35808697-61616D6E-40D3-41F0-AFB3-0EFB62F40F39Q36212799-2EF6E116-A250-4E25-B00E-7D3716A2BB86Q37382552-8D05C406-76AC-464E-A909-887264D01AFEQ37463065-9566950A-5CD3-4933-9561-1889DCE27A89Q37618803-1691E647-7319-4935-AF02-586AF7ED5CFEQ37636802-6530C200-6B94-4A81-A482-363B0EBD624BQ37702562-6265B212-BB79-4A3E-8E4C-E0F9BFEBD76EQ38110962-6920DBFC-8618-4CF6-A8F9-50FACB1A4A54Q38264442-5D537FD8-52F9-4124-B5BC-64CCD0A83FCDQ38284597-FAC071C1-3220-491E-8ED1-8A0937F66B56Q39015252-F8710764-C90D-4279-81AF-22851CF72FF9Q39115898-0DBE9322-EF0F-462C-98AE-B48050F2EE4DQ43194164-C3929BFD-BA1B-4F4D-B737-5BC539019189Q47753559-1C5F2081-4CCA-495B-9D45-0E50DF286A0AQ50321726-7A950B27-5163-4D7F-8D67-4D4793C44090
P2860
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
@ast
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
@en
type
label
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
@ast
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
@en
prefLabel
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
@ast
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
@en
P2093
P356
P1433
P1476
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
@en
P2093
D P Kelsen
L P Leichman
R G Wadleigh
P304
P356
10.1093/ANNONC/MDM004
P577
2007-03-09T00:00:00Z